Overview
Lobbying Costs
75,000€
Financial year: Jul 2018 - Jun 2019
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
ResMed (RMD)
EU Transparency Register
209143033529-94 First registered on 21 Dec 2018
Goals / Remit
ResMed (NYSE: RMD, ASX: RMD), is a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring. The company manufactures cloud-connected durable medical equipment used to diagnose and treat sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Through our devices, patients are remotely monitored at home with connected care and many use myAir™, a patient engagement mobile application. Its 7,500-member team strives to improve patients’ quality of life, promote therapy adherence, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.
Main EU files targeted
- Implementation of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR)
- Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (GDPR)
- Cybersecurity Package: Proposal for a Regulation on ENISA, the "EU Cybersecurity Agency", and on Information and Communication Technology cybersecurity certification (''Cybersecurity Act'')
- Commission Communication on enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society
- Horizon 2020 and Horizon Europe framework programmesAddress
Head Office
9001 Spectrum Center Blvd
San Diego 92123
UNITED STATESEU Office
Grote Steenweg 50
Kontich-Waarloos 2550
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 06 Nov 2019
Name Start date End Date Justyna VANDENBOSCH 25 Jan 2024 24 Jan 2025 Francesca RISSO 24 Jan 2024 23 Jan 2025 Ms Justyna VANDENBOSCH 25 Jan 2024 15 Apr 2024 Ms Francesca RISSO 24 Jan 2024 15 Apr 2024 Ms Justyna VANDENBOSCH 25 Jan 2023 25 Jan 2024 Ms Francesca RISSO 22 Oct 2022 21 Oct 2023 Complementary Information
None declared
Person in charge of EU relations
Ms Justyna Vandenbosch (Director, Government Affairs Europe)
Person with legal responsibility
Ms Larissa D'Andrea (Senior Director, Global Government Affairs)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
MedTech Europe: https://www.medtecheurope.org/
Personal Connected Health Alliance: https://www.pchalliance.org/Member organisations
None declared
-
Financial Data
Closed financial year
Jul 2018 - Jun 2019
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
- Engaging with European Commission officials including Commissioners, cabinet members and services in DGs such as DG Connect, DG Grow, DG Sante, and DG Research; with MEPS and secretariats on committees such as IMCO, ENVI and ITRE; and with officials in the Working Party on Pharmaceuticals and Medical Devices in the Council of Ministers and Permanent Representations
- Attending public hearings and events hosted in the EU institutions related to healthcare and digital policyOther activities
None declared
- Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 25 Mar 2020 Location Videoconference Subject Videoconference with CEOs on COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists - FUNDACIÓN CLUSTER DE EMPRESAS DE AUTOMOCIÓN DE GALICIA
- SAFRAN
- Airbus
- MONDRAGON CORPORACION COOPERATIVA S. COOP
- Medtronic
- Bayerische Motoren Werke Aktiengesellschaft
- Smiths Group plc
- Mercedes-Benz Group AG
- Vyaire Medical
- Leonardo S.p.A.
- thyssenkrupp Steel Europe AG
- Siemens AG
- Saab AB
- General Electric Company
- Koninklijke Philips
-
Date 25 Mar 2020 Location Videoconference Subject Videoconference with CEOs on COVID-19 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists - FUNDACIÓN CLUSTER DE EMPRESAS DE AUTOMOCIÓN DE GALICIA
- MONDRAGON CORPORACION COOPERATIVA S. COOP
- Siemens AG
- Mercedes-Benz Group AG
- Airbus
- General Electric Company
- Medtronic
- SAFRAN
- Koninklijke Philips
- Saab AB
- Leonardo S.p.A.
- Smiths Group plc
- Bayerische Motoren Werke Aktiengesellschaft
- thyssenkrupp Steel Europe AG
- Vyaire Medical
- Meetings